Literature DB >> 23370465

Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression.

Melissa-Rose Abrahams1, Florette K Treurnicht, Nobubelo K Ngandu, Sarah A Goodier, Jinny C Marais, Helba Bredell, Ruwayhida Thebus, Debra de Assis Rosa, Koleka Mlisana, Cathal Seoighe, Salim Abdool Karim, Clive M Gray, Carolyn Williamson.   

Abstract

OBJECTIVE(S): There is limited information on full-length genome sequences and the early evolution of transmitted HIV-1 subtype C viruses, which constitute the majority of viruses spread in Africa. The purpose of this study was to characterize the earliest changes across the genome of subtype C viruses following transmission, to better understand early control of viremia.
DESIGN: We derived the near full-length genome sequence responsible for clinical infection from five HIV subtype C-infected individuals with different disease progression profiles and tracked adaptation to immune responses in the first 6 months of infection.
METHODS: Near full-length genomes were generated by single genome amplification and direct sequencing. Sequences were analyzed for amino acid mutations associated with cytotoxic T lymphocyte (CTL) or antibody-mediated immune pressure, and for reversion.
RESULTS: Fifty-five sequence changes associated with adaptation to the new host were identified, with 38% attributed to CTL pressure, 35% to antibody pressure, 16% to reversions and the remainder were unclassified. Mutations in CTL epitopes were most frequent in the first 5 weeks of infection, with the frequency declining over time with the decline in viral load. CTL escape predominantly occurred in nef, followed by pol and env. Shuffling/toggling of mutations was identified in 81% of CTL epitopes, with only 7% reaching fixation within the 6-month period.
CONCLUSION: There was rapid virus adaptation following transmission, predominantly driven by CTL pressure, with most changes occurring during high viremia. Rapid escape and complex escape pathways provide further challenges for vaccine protection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370465      PMCID: PMC3720865          DOI: 10.1097/QAD.0b013e32835cab64

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  62 in total

1.  Not so different after all: a comparison of methods for detecting amino acid sites under selection.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2005-02-09       Impact factor: 16.240

2.  HyPhy: hypothesis testing using phylogenies.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost; Spencer V Muse
Journal:  Bioinformatics       Date:  2004-10-27       Impact factor: 6.937

3.  CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.

Authors:  Anju Bansal; Ethan Gough; Steffanie Sabbaj; Doug Ritter; Karina Yusim; Greg Sfakianos; Grace Aldrovandi; Richard A Kaslow; Craig M Wilson; Mark J Mulligan; J Michael Kilby; Paul A Goepfert
Journal:  AIDS       Date:  2005-02-18       Impact factor: 4.177

4.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.

Authors:  J Tang; C Costello; I P Keet; C Rivers; S Leblanc; E Karita; S Allen; R A Kaslow
Journal:  AIDS Res Hum Retroviruses       Date:  1999-03-01       Impact factor: 2.205

6.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

7.  Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.

Authors:  Todd M Allen; Marcus Altfeld; Shaun C Geer; Elizabeth T Kalife; Corey Moore; Kristin M O'sullivan; Ivna Desouza; Margaret E Feeney; Robert L Eldridge; Erica L Maier; Daniel E Kaufmann; Matthew P Lahaie; Laura Reyor; Giancarlo Tanzi; Mary N Johnston; Christian Brander; Rika Draenert; Jurgen K Rockstroh; Heiko Jessen; Eric S Rosenberg; Simon A Mallal; Bruce D Walker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.

Authors:  Nicola A Jones; Xiping Wei; Darren R Flower; Mailee Wong; Franziska Michor; Michael S Saag; Beatrice H Hahn; Martin A Nowak; George M Shaw; Persephone Borrow
Journal:  J Exp Med       Date:  2004-11-15       Impact factor: 14.307

View more
  7 in total

1.  Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.

Authors:  Gama P Bandawe; Penny L Moore; Lise Werner; Elin S Gray; Daniel J Sheward; Maphuti Madiga; Andile Nofemela; Ruwayhida Thebus; Jinny C Marais; Leonard Maboko; Salim S Abdool Karim; Michael Hoelscher; Lynn Morris; Carolyn Williamson
Journal:  J Infect Dis       Date:  2014-11-14       Impact factor: 5.226

Review 2.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

3.  Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction.

Authors:  Justin De La Cruz; Thomas Vollbrecht; Patricia Frohnen; Hwee L Ng; Eric S Daar; Otto O Yang; Martha J Lewis
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

4.  High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.

Authors:  Kamini Gounder; Nagavelli Padayachi; Jaclyn K Mann; Mopo Radebe; Mammekwa Mokgoro; Mary van der Stok; Lungile Mkhize; Zenele Mncube; Manjeetha Jaggernath; Tarylee Reddy; Bruce D Walker; Thumbi Ndung'u
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.

Authors:  Dieter Mielke; Gama Bandawe; Justin Pollara; Melissa-Rose Abrahams; Tinashe Nyanhete; Penny L Moore; Ruwayhida Thebus; Nicole L Yates; John C Kappes; Christina Ochsenbauer; Nigel Garrett; Salim Abdool Karim; Georgia D Tomaras; David Montefiori; Lynn Morris; Guido Ferrari; Carolyn Williamson
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

6.  HIV-1 p24Gag adaptation to modern and archaic HLA-allele frequency differences in ethnic groups contributes to viral subtype diversification.

Authors:  Nicolaas C Kist; Ben Lambert; Samuel Campbell; Aris Katzourakis; Daniel Lunn; Philippe Lemey; Astrid K N Iversen
Journal:  Virus Evol       Date:  2020-12-12

Review 7.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.